Invesco Ltd. Revolution Medicines, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 147,246 shares of RVMD stock, worth $6.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

147,246

Previous 98,551 49.41%

Holding current value

$6.37 Million

Previous $3.82 Million 74.45%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$36.92 - $47.94 $1.8 Million - $2.33 Million	48,695 Added 49.41%	147,246 $6.67 Million
Q2 2024 Aug 13, 2024	BUY	$30.14 - $40.68 $124,176 - $167,601	4,120 Added 4.36%	98,551 $3.82 Million
Q1 2024 May 14, 2024	SELL	$26.56 - $33.55 $913,318 - $1.15 Million	-34,387 Reduced 26.69%	94,431 $3.04 Million
Q4 2023 Feb 12, 2024	SELL	$18.35 - $34.12 $1.41 Million - $2.61 Million	-76,584 Reduced 37.28%	128,818 $3.69 Million
Q3 2023 Nov 13, 2023	BUY	$25.17 - $35.05 $3.39 Million - $4.72 Million	134,536 Added 189.85%	205,402 $5.69 Million
Q2 2023 Aug 11, 2023	BUY	$20.28 - $27.0 $209,857 - $279,396	10,348 Added 17.1%	70,866 $1.9 Million
Q1 2023 May 12, 2023	BUY	$20.76 - $30.09 $704,283 - $1.02 Million	33,925 Added 127.57%	60,518 $1.31 Million
Q4 2022 Feb 13, 2023	SELL	$17.68 - $25.53 $5,816 - $8,399	-329 Reduced 1.22%	26,593 $633,000
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $66,994 - $99,762	3,837 Added 16.62%	26,922 $530,000
Q2 2022 Aug 15, 2022	BUY	$14.54 - $27.17 $2,122 - $3,966	146 Added 0.64%	23,085 $450,000
Q1 2022 May 16, 2022	BUY	$17.31 - $26.4 $3,565 - $5,438	206 Added 0.91%	22,939 $586,000
Q4 2021 Feb 14, 2022	BUY	$24.35 - $33.7 $72,660 - $100,560	2,984 Added 15.11%	22,733 $573,000
Q3 2021 Nov 15, 2021	SELL	$23.95 - $33.41 $92,758 - $129,396	-3,873 Reduced 16.4%	19,749 $543,000
Q2 2021 Aug 17, 2021	BUY	$29.0 - $47.44 $422,472 - $691,105	14,568 Added 160.9%	23,622 $750,000
Q1 2021 May 17, 2021	SELL	$37.21 - $54.43 $301,363 - $440,828	-8,099 Reduced 47.22%	9,054 $415,000
Q4 2020 Feb 16, 2021	BUY	$30.19 - $45.49 $517,849 - $780,289	17,153 New	17,153 $679,000
Q3 2020 Nov 16, 2020	SELL	$22.61 - $34.8 $372,725 - $573,678	-16,485 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$19.65 - $39.34 $323,930 - $648,519	16,485 New	16,485 $521,000

Others Institutions Holding RVMD

# of Institutions

266

Shares Held

161M

Call Options Held

260K

Put Options Held

620K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account